L-Nutra Inc. secured a $36.5 million investment from Mubadala Investment Company to launch a joint venture in Abu Dhabi, aimed at advancing nutritional technologies for healthy aging in the MENA region.

Information on the Target

L-Nutra Inc. is a pioneering company in the field of nutri-technology, dedicated to advancing science-based nutrition with a focus on promoting longevity and utilizing nutrition as a form of medicine. Recently, the company announced a significant investment of $36.5 million as part of its Series D funding round, bringing the total amount raised in this series to $83.5 million. L-Nutra aims to enhance human health and promote disease remission through its innovative nutritional therapies.

As the first company to specialize in nutri-technology, L-Nutra has dedicated years to research and development in the nutrition space. Its mission aligns with delivering clinically validated nutrition programs designed to support individuals on their journey to healthy longevity. The company's programs are rooted in extensive research and are backed by numerous clinical trials, positioning it as a leader in the field.

Industry Overview in the Target’s Specific Country

The longevity and health tech industry in the United Arab Emirates (UAE), particularly in Abu Dhabi, is rapidly evolving. The UAE government has laid out ambitious plans to position the region as a global hub for health sc